University of Cambridge > Talks.cam > Cambridge University Biological Society > Antibodies Vs Alzheimer's

  Browse A-Z

Log in

University Account External (via Google)

🔐 Log In

Information on

Subscribing to talksdetails Finding a talkdetails Adding a talkdetails Disseminating talksdetails Help and Documentationdetails

ℹ️ Information

Antibodies Vs Alzheimer's

Download to your calendar using vCal

If you have a question about this talk, please contact Toby Baker .

Worldwide, it is estimated that 50 million people suffer from dementia and that this number will rise to 140 millions by 2050, unless effective treatments are found. Antibodies are powerful tools in clinical research, thanks to their strong binding ability and high specificity. Dr Aprile will present how rational design and protein engineering can be used to generate antibodies as potential therapeutics for Alzheimer’s disease, the most common form of dementia.

This talk is part of the Cambridge University Biological Society series.

This talk is included in these lists:

Note that ex-directory lists are not shown.

Other lists

Institute of Metabolic Science (IMS), Level 4 ATC, Seminar rooms 1,2 & 3 Writing Service Hybrid: in-person in Cambridge & online via Teams

Other talks

CONFERENCE: Chemical and material sciences enabled by AI and automation Director's Briefing LCLU Annual Talk: The Early Aqueous Environment of Mars Inferred From Mission Lifetime Results by the Curiosity Rover at Gale Crater Title TBC Topology of the Ritz energy landscape Online Causal Inference Seminar
 

© 2006-2025 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity